Showing results (41-50 of 54) with videos related to
Sort By:
Pageof 6
Neurology. Clinical Practice|November 30, 2017
Perspectives on marijuana use and effectiveness: A survey of NARCOMS participantsStacey S Cofield, Amber Salter, Tuula Tyry, et al.Multiple Sclerosis and Related Disorders|January 29, 2019
Validation of the SymptoMScreen with performance-based or clinician-assessed outcomesKathryn C Fitzgerald, Amber Salter, Tuula Tyry, et al.International Journal of MS Care|December 15, 2015
Care Partners and Multiple Sclerosis: Differential Effect on Men and WomenTamara McKenzie, Mary Elizabeth Quig, Tuula Tyry, et al.Neurology|July 1, 2016
Health insurance affects the use of disease-modifying therapy in multiple sclerosisGuoqiao Wang, Ruth Ann Marrie, Amber R Salter, et al.Multiple Sclerosis and Related Disorders|March 7, 2018
A survey of dietary characteristics in a large population of people with multiple sclerosisKathryn C Fitzgerald, Tuula Tyry, Amber Salter, et al.Neurology|March 15, 2019
A survey of risk tolerance to multiple sclerosis therapiesRobert J Fox, Carol Cosenza, Lauren Cripps, et al.Journal of Social Work in Disability & Rehabilitation|December 1, 2011
A pilot study of Latinos with multiple sclerosis: demographic, disease, mental health, and psychosocial characteristicsRobert J Buchanan, Miguel A Zuniga, Genny Carrillo-Zuniga, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|September 4, 2013
The impact of sexual dysfunction on health-related quality of life in people with multiple sclerosisLaura C Schairer, Frederick W Foley, Vance Zemon, et al.Ethnicity & Disease|February 11, 2011
Comparisons of Latinos, African Americans, and Caucasians with multiple sclerosisRobert J Buchanan, Miguel A Zuniga, Genny Carrillo-Zuniga, et al.Patient Preference and Adherence|July 22, 2014
Patient perspectives on switching disease-modifying therapies in the NARCOMS registryAmber R Salter, Ruth Ann Marrie, Neetu Agashivala, et al.Pageof 6